Literature DB >> 25514902

Cardiovascular risk factors and the risk of Parkinson's disease.

M Vikdahl1, L Bäckman1, I Johansson2, L Forsgren3, L Håglin1.   

Abstract

BACKGROUND/
OBJECTIVES: The objective of this study was to investigate whether serum triglycerides (S-TG), cholesterol, blood pressure and waist/height ratio are risk factors for Parkinson's disease (PD). SUBJECTS AND METHODS: A population-based sample within the Northern Sweden Health and Disease Study (NSHDS) was used in this study (n=101 790 subjects). Cases with PD were identified prospectively in a community-based study of idiopathic Parkinsonism in the period 2004-2009 in the county of Västerbotten in northern Sweden. The case database obtained was crosslinked to the NSHDS. Eighty-four of 147 patients with PD had visited the primary health care 2-8 years before diagnosis for participation in the NSHDS. For each case, four referents from the NSHDS population were selected, matched for sex, age, year of health survey, subcohort and geographic area.
RESULTS: Cases had lower mean S-TG levels (P=0.007). After stratification for sex, the lower S-TG remained significant for men (P=0.006) but not for women (P=0.450), and these were confirmed by the conditional logistic regression for all cases, none adjusted (hazard ratio (HR): 0.65; 95% confidence interval (CI): 0.42, 0.99) and after adjusting for age, body mass index (BMI) and physical activity (HR: 0.61; 95% CI: 0.39, 0.96). Systolic blood pressure (SBP) was negatively associated with PD risk after adjustments for age, BMI and physical activity (HR: 0.98; 95% CI: 0.97-0.99). Smoking and former smoking were associated with a reduced risk for PD.
CONCLUSIONS: We found lower S-TG and SBP 2-8 years before a diagnosis of PD. Smoking was confirmed to be negatively associated with PD, whereas recreational activity indicates a risk for women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25514902     DOI: 10.1038/ejcn.2014.259

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  27 in total

1.  The role of physical exercise in the occurrence of Parkinson's disease.

Authors:  A J Sasco; R S Paffenbarger; I Gendre; A L Wing
Journal:  Arch Neurol       Date:  1992-04

2.  Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

Authors:  P K Morrish; J S Rakshi; D L Bailey; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

3.  The stressful life events and Parkinson's disease: a case-control study.

Authors:  Hristina Vlajinac; Sandra Sipetic; Jelena Marinkovic; Isidora Ratkov; Jadranka Maksimovic; Eleonora Dzoljic; Vladimir Kostic
Journal:  Stress Health       Date:  2012-03-07       Impact factor: 3.519

4.  Midlife adiposity and the future risk of Parkinson's disease.

Authors:  R D Abbott; G W Ross; L R White; J S Nelson; K H Masaki; C M Tanner; J D Curb; P L Blanchette; J S Popper; H Petrovitch
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

5.  Serum cholesterol levels and the risk of Parkinson's disease.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Am J Epidemiol       Date:  2006-08-11       Impact factor: 4.897

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Metabolic markers or conditions preceding Parkinson's disease: a case-control study.

Authors:  Rodolfo Savica; Brandon R Grossardt; J Eric Ahlskog; Walter A Rocca
Journal:  Mov Disord       Date:  2012-06-01       Impact factor: 10.338

8.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions.

Authors:  Göran Hallmans; Asa Agren; Gerd Johansson; Anders Johansson; Birgitta Stegmayr; Jan-Håkan Jansson; Bernt Lindahl; Olle Rolandsson; Stefan Söderberg; Mats Nilsson; Ingegerd Johansson; Lars Weinehall
Journal:  Scand J Public Health Suppl       Date:  2003       Impact factor: 3.021

9.  Total cholesterol and the risk of Parkinson disease.

Authors:  G Hu; R Antikainen; P Jousilahti; M Kivipelto; J Tuomilehto
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

10.  Community participation and sustainability--evidence over 25 years in the Västerbotten Intervention Programme.

Authors:  Margareta Norberg; Yulia Blomstedt; Göran Lönnberg; Lennarth Nyström; Hans Stenlund; Stig Wall; Lars Weinehall
Journal:  Glob Health Action       Date:  2012-12-17       Impact factor: 2.640

View more
  16 in total

1.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

2.  Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.

Authors:  Cristina Barbagallo; Giovanni Mostile; Gloriangela Baglieri; Flavia Giunta; Antonina Luca; Loredana Raciti; Mario Zappia; Michele Purrello; Marco Ragusa; Alessandra Nicoletti
Journal:  Cell Mol Neurobiol       Date:  2019-11-06       Impact factor: 5.046

3.  Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

Authors:  Robin M Voigt; Zeneng Wang; J Mark Brown; Phillip A Engen; Ankur Naqib; Christopher G Goetz; Deborah A Hall; Leo Verhagen Metman; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2022-05-30       Impact factor: 7.046

4.  Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson's Disease: A Meta-Analysis and Systematic Review.

Authors:  Xue Hong; Wenting Guo; Shanshan Li
Journal:  Int J Clin Pract       Date:  2022-06-09       Impact factor: 3.149

5.  Association between carotid plaque and Parkinson's disease.

Authors:  Lan-Yun Yan; Qing-Fang He; Min-Yan Lu; Sheng-Long Wang; Zhi-Qiang Qi; Hai-Rong Dong
Journal:  Ann Transl Med       Date:  2019-03

6.  Alteration in the Cerebrospinal Fluid Lipidome in Parkinson's Disease: A Post-Mortem Pilot Study.

Authors:  Joaquín Fernández-Irigoyen; Paz Cartas-Cejudo; Marta Iruarrizaga-Lejarreta; Enrique Santamaría
Journal:  Biomedicines       Date:  2021-04-29

7.  Dietary cholesterol intake and stroke risk: a meta-analysis.

Authors:  Pengfei Cheng; Junxi Pan; Jinjun Xia; Wen Huang; Shunjie Bai; Xiaofeng Zhu; Weihua Shao; Haiyang Wang; Peng Xie; Fengli Deng
Journal:  Oncotarget       Date:  2018-01-04

8.  Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.

Authors:  Ga Eun Nam; Seon Mee Kim; Kyungdo Han; Nan Hee Kim; Hye Soo Chung; Jin Wook Kim; Byoungduck Han; Sung Jung Cho; Ji Hee Yu; Yong Gyu Park; Kyung Mook Choi
Journal:  PLoS Med       Date:  2018-08-21       Impact factor: 11.069

9.  Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adults.

Authors:  Jennifer Kizza; Sarah Lewington; Benjamin Mappin-Kasirer; Iain Turnbull; Yu Guo; Zheng Bian; Yiping Chen; Ling Yang; Zhengming Chen; Robert Clarke
Journal:  Ann Clin Transl Neurol       Date:  2019-03-10       Impact factor: 4.511

10.  Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.

Authors:  Maureen Leehey; Sheng Luo; Saloni Sharma; Anne-Marie A Wills; Jacquelyn L Bainbridge; Pei Shieen Wong; David K Simon; Jay Schneider; Yunxi Zhang; Adriana Pérez; Rohit Dhall; Chadwick W Christine; Carlos Singer; Franca Cambi; James T Boyd
Journal:  Neurology       Date:  2017-09-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.